UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic Medication Nonadherence and Potentially Preventable Healthcare Utilization and Spending Among Medicare Patients

Journal of general internal medicine : JGIM, 2022-11, Vol.37 (14), p.3645-3652

2022

Volltextzugriff (PDF)

A tutorial on the use of instrumental variables in pharmacoepidemiology

Pharmacoepidemiology and drug safety, 2017-04, Vol.26 (4), p.357-367

2017

Volltextzugriff (PDF)

Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis

Diabetes care, 2022-04, Vol.45 (4), p.919-927

2022

Volltextzugriff (PDF)

Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications

JAMA internal medicine, 2015-03, Vol.175 (3), p.458

2015

Volltextzugriff (PDF)

Reports of Lactic Acidosis Attributed to Metformin, 2015-2018

Diabetes care, 2020-01, Vol.43 (1), p.244-246

2020

Volltextzugriff (PDF)

Metformin in 2019

JAMA : the journal of the American Medical Association, 2019-05, Vol.321 (19), p.1926

2019

Volltextzugriff (PDF)

The Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Antidiabetic Medication under Conditions of Clinical Uncertainty

Diabetes care, 2024-09

2024

Volltextzugriff (PDF)

Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes

Diabetes care, 2020-06, Vol.43 (6), p.e66-e67

2020

Volltextzugriff (PDF)

Prescriber Uncertainty as Opportunity to Improve Care of Type 2 Diabetes with Chronic Kidney Disease: Mixed Methods Study

Journal of general internal medicine : JGIM, 2023-05, Vol.38 (6), p.1476-1483

2023

Volltextzugriff (PDF)

Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition

Breast cancer research and treatment, 2024, Vol.203 (1), p.85-93

2024

Volltextzugriff (PDF)

Sodium–glucose cotransporter 2 inhibitor-induced postoperative euglycaemic diabetic ketoacidosis after pancreatectomy

British journal of surgery, 2023-04, Vol.110 (5), p.545-547

2023

Volltextzugriff (PDF)

Climate Change and Ambient Temperature Extremes: Association With Serious Hypoglycemia, Diabetic Ketoacidosis, and Sudden Cardiac Arrest/Ventricular Arrhythmia in People With Type 2 Diabetes

Diabetes care, 2022-11, Vol.45 (11), p.e171-e173

2022

Volltextzugriff (PDF)

Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience

Circulation (New York, N.Y.), 2016-11, Vol.134 (18), p.1405-1408

2016

Volltextzugriff (PDF)

Proposals to Conduct Randomized Controlled Trials Without Informed Consent: a Narrative Review

Journal of general internal medicine : JGIM, 2016-12, Vol.31 (12), p.1511-1518

2016

Volltextzugriff (PDF)

Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence

Trends in endocrinology and metabolism, 2017-08, Vol.28 (8), p.561-586

2017

Volltextzugriff (PDF)

Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246

Diabetes care, 2020-10, Vol.43 (10), p.e159-e159

2020

Volltextzugriff (PDF)

Review of Metformin Use for Type 2 Diabetes Prevention

American journal of preventive medicine, 2018-10, Vol.55 (4), p.565-574

2018

Volltextzugriff (PDF)

Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia

Diabetes care, 2018-04, Vol.41 (4), p.713-722

2018

Volltextzugriff (PDF)

Spotlight commentary: A role for real‐world evidence to inform the clinical care of patients with diabetes mellitus

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4549-4551

2021

Volltextzugriff (PDF)

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

Cancer medicine (Malden, MA), 2022-04, Vol.11 (8), p.1796-1804

2022

Volltextzugriff (PDF)

Baseline haemoglobin A1c and the risk of COVID‐19 hospitalization among patients with diabetes in the INSIGHT Clinical Research Network

Diabetic medicine, 2022-05, Vol.39 (5), p.e14815-n/a

2022

Volltextzugriff (PDF)

Instrumental Variable Methods for Continuous Outcomes That Accommodate Nonignorable Missing Baseline Values

American journal of epidemiology, 2017-06, Vol.185 (12), p.1233-1239

2017

Volltextzugriff (PDF)

Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder

PloS one, 2010-12, Vol.5 (12), p.e15463-e15463

2010

Volltextzugriff (PDF)

Angiotensin‐Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia

Clinical pharmacology and therapeutics, 2022-01, Vol.111 (1), p.218-226

2022

Volltextzugriff (PDF)

Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study

Pharmacoepidemiology and drug safety, 2018-01, Vol.27 (1), p.9-18

2018

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(175)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(204)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(111)
Humans
(82)
Female
(45)
Male
(41)
Diabetes
(36)
Middle Aged
(32)
Aged
(30)
Diabetes Mellitus
(26)
Endocrinology & Metabolism
(21)
Retrospective Studies
(21)
General & Internal Medicine
(20)
Medicine, General & Internal
(20)
Adult
(19)
Antidiabetics
(19)
Diabetes Mellitus, Type 2 - Drug Therapy
(19)
Hypoglycemic Agents - Therapeutic Use
(19)
Metformin
(19)
Cohort Studies
(18)
Hypoglycemic Agents - Adverse Effects
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Chronic Medication Nonadherence and Potentially Preventable Healthcare Utilization and Spending Among Medicare Patients

A tutorial on the use of instrumental variables in pharmacoepidemiology

Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis

Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications

Reports of Lactic Acidosis Attributed to Metformin, 2015-2018

Metformin in 2019

The Large Language Model GPT-4 Compared to Endocrinologist Responses on Initial Choice of Antidiabetic Medication under Conditions of Clinical Uncertainty

Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes

Prescriber Uncertainty as Opportunity to Improve Care of Type 2 Diabetes with Chronic Kidney Disease: Mixed Methods Study

Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition

Sodium–glucose cotransporter 2 inhibitor-induced postoperative euglycaemic diabetic ketoacidosis after pancreatectomy

Climate Change and Ambient Temperature Extremes: Association With Serious Hypoglycemia, Diabetic Ketoacidosis, and Sudden Cardiac Arrest/Ventricular Arrhythmia in People With Type 2 Diabetes

Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience

Proposals to Conduct Randomized Controlled Trials Without Informed Consent: a Narrative Review

Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence

Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246

Review of Metformin Use for Type 2 Diabetes Prevention

Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia

Spotlight commentary: A role for real‐world evidence to inform the clinical care of patients with diabetes mellitus

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

Baseline haemoglobin A1c and the risk of COVID‐19 hospitalization among patients with diabetes in the INSIGHT Clinical Research Network

Instrumental Variable Methods for Continuous Outcomes That Accommodate Nonignorable Missing Baseline Values

Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder

Angiotensin‐Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia

Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study

Suchergebnisse filtern